ENTITY
Shandong Weigao Group Medical Polymer

Shandong Weigao Group Medical Polymer (1066 HK)

82
Analysis
Health Care • China
Shandong Weigao Group Medical Polymer Co. Ltd. is primarily engaged in the research and development, production, and sale of medical devices, focusing on single-use medical device products. Their extensive product portfolio includes consumables such as infusion sets, syringes, and blood bags, alongside orthopedic, interventional, pharma packaging, and blood management products. The company was founded in 1988 and is headquartered in Weihai, China.
more
•03 Aug 2016 19:56

Chinese Choose Not to Have More Children

Chinese people are actively choosing not to have further children and this will lead inexorably to a population collapse during the balance of this...

Logo
420 Views
Share
•26 Feb 2016 05:38

Coming to the HKEX Soon....................

Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...

Share
•18 Feb 2016 23:01

Time to Go Shopping for Healthcare

The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...

Share
•09 Jul 2015 06:01

Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder

China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...

Share
•01 Jul 2015 22:01

China ADR Privatizations: The Challenges of Getting the Best Deal

The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...

Share
x